Matsushita Maiko 松下麻衣子

… Alternative Names

MATSUSHITA Maiko 松下麻衣子

Less

Researcher Number	10327520
Other IDs
Affiliation (Current)	2025: 慶應義塾大学, 薬学部(芝共立), 教授
Affiliation (based on the past Project Information) *help	2024: 慶應義塾大学, 薬学部(芝共立), 教授 2023: 慶應義塾大学, 薬学部(芝共立), 准教授 2018 – 2020: 慶應義塾大学, 薬学部(芝共立), 准教授 2016: 慶應義塾大学, 薬学部(芝共立), 准教授 2015: 慶應義塾大学, 薬学部, 准教授 … More 2014: 慶應義塾大学, 薬学部, 講師 2010 – 2011: 慶應義塾大学, 薬学部, 講師 2008 – 2009: Keio University, 医学部, 助教 Less
Review Section/Research Field	Principal Investigator Hematology / Basic Section 56030:Urology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related / Dermatology Except Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator 免疫増強薬 / がん抗原 / 去勢抵抗性前立腺癌 / 細胞外小胞 / 膵がん / 複合免疫療法 / 免疫学的細胞死 / 多発性骨髄腫 / エピジェネティクス / 免疫療法 … More / T細胞 / 脱メチル化剤 / CTL / 白血病幹細胞 / 腫癌免疫 / 腫瘍免疫 / 癌幹細胞 / 皮膚腫瘍学 / 腫瘍抗原 / 制御性T細胞 / 悪性リンパ腫 … More Except Principal Investigator チロシンキナーゼ阻害 / ドラッグリポジショニング / オートファジー / 上皮間葉系移行 / ハイリスク多発性骨髄腫 Less

去勢抵抗性前立腺癌に対する細胞外小胞スクリーニング法を用いた新規免疫増強薬の探索Principal Investigator
- Principal Investigator
  
  松下麻衣子
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Keio University
Why multiple myeloma is incurable?Exploitation of molecular pathogenesis and development of overcoming drug by targeting autophagy
- Principal Investigator
  
  服部豊
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Keio University
Development of novel combined immunotherapy using in silico screening systemPrincipal Investigator
- Principal Investigator
  
  Matsushita Maiko
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Keio University
Development of novel immunotherapy targeting leukemic stem cells.Principal Investigator
- Principal Investigator
  
  Matsushita Maiko
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
Development of immunotherapy targeting melanoma stem cells.Principal Investigator
- Principal Investigator
  
  MATSUSHITA Maiko
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Dermatology
- Research Institution
  Keio University
Analysis of induction mechanisms for tumor antigen-specific regulatory T cells in lymphomaPrincipal Investigator
- Principal Investigator
  
  MATSUSHITA Maiko
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Keio University

All 2023 2019 2018 2016 2015 2012 2009 Other

All Journal Article Presentation

[Journal Article] GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase.2023
- Author(s)
  Okayama M, Fujimori K, Sato M, Samata K, Kurita K, Sugiyama H, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Ichikawa D, Matsushita M, Hirao M, Kunieda H, Yamazaki K, Hattori Y.
- Journal Title
  
  Cancer Medicine
  
  Volume: - Issue: 8 Pages: 9749-9759
- DOI
  10.1002/cam4.5691
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08763, KAKENHI-PROJECT-23K07869, KAKENHI-PROJECT-22K19387
[Journal Article] Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells2023
- Author(s)
  Matsushita Maiko、Kashiwazaki Sho、Kamiko Satoshi、Kobori Michio、Osada Makoto、Kunieda Hisako、Hirao Maki、Ichikawa Daiju、Hattori Yutaka
- Journal Title
  
  Pharmaceuticals
  
  Volume: 16 Issue: 10 Pages: 1367-1367
- DOI
  10.3390/ph16101367
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07869
[Journal Article] Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication2009
- Author(s)
  Zhong XS, Matsushita M, Plotkin J, Riviere I, Sadelain M.
- Journal Title
  
  Mol Ther. 18
  
  Pages: 413-420
- Data Source
  KAKENHI-PROJECT-20790681
[Journal Article] Chimeric antigen receptors combining, 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.2009
- Author(s)
  Zhong XS, Matsushita M, Plotkin J, Riviere I, Sadelain M.
- Journal Title
  
  Mol Ther. 18
  
  Pages: 413-420
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20790681
[Presentation] 多発性骨髄腫に対して免疫原性細胞死を誘導する天然物由来化合物の安全性と有効性の検討2023
- Author(s)
  藤浪太晴、栗田昂希、松下麻衣子、市川大樹、須藤豊、服部豊
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] エピジェネテイック因子CDYL2は多発性骨髄腫におけるレナリドミド感受性を減弱する2023
- Author(s)
  市川大樹、松下麻衣子、服部豊
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] Characteristics of Cytotoxic T Cells against Myeloma Cells for Adoptive Immunotherapy.2019
- Author(s)
  Saku Saito, Maiko Matsushita, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
- Organizer
  第10回日本血液学会国際シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] A novel candidate for immunological target in treatment of multiple myeloma.2019
- Author(s)
  Maiko Matsushita, Saku Saito, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
- Organizer
  An AACR Special Conference on Tumor Immunology and Immunotherapy
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] プロテアソーム阻害薬の免疫原性細胞死による免疫調節機能2018
- Author(s)
  柏崎翔、神子智史、宇於崎涼、山本智史、市川大樹、服部豊、松下麻衣子
- Organizer
  第80回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] Analysis of immunogenic cell death (ICD) induced in multiple myeloma cells.2018
- Author(s)
  Maiko Matsushita, Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomohumi Yamamoto, Daiju Ichikawa, Yutaka Hattori
- Organizer
  CRI-CIMT-EATI-AACR Fourth International Cancer immunotherapy conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] Immunogenicity of Novel Antigen Expressed in Leukemia Stem Cells.2016
- Author(s)
  Ozawa K, Matsushita M, Yokoe S, Kanchi S, Uchiumi A, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Kawakami Y, Okamoto S, Hattori Y.
- Organizer
  The 5thJCA-AACR Joint Conference
- Place of Presentation
  東京ベイ舞浜ホテル（千葉県浦安市）
- Year and Date
  2016-07-13
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] 白血病幹細胞に発現する新規がん精巣抗原の同定2015
- Author(s)
  小澤光司、松下麻衣子、中村美紀、鈴木拓真、市川大樹、塚本信夫、河上裕、服部豊
- Organizer
  第12回日本免疫治療学研究会学術集会
- Place of Presentation
  東京都　東京ガーデンパレス
- Year and Date
  2015-02-28
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析2015
- Author(s)
  神地沙織、小澤光司、松下麻衣子、松木絵里、櫻井政寿、雁金大樹、市川大樹、岡本真一郎、服部豊
- Organizer
  第７回血液疾患免疫療法研究会学術集会
- Place of Presentation
  東京大学国際学術研究センター内　伊藤謝恩ホール（東京都文京区）
- Year and Date
  2015-09-26
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI2015
- Author(s)
  Matsushita M, Koji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.
- Organizer
  30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC）
- Place of Presentation
  メリーランド州ナショナルハーバー（アメリカ合衆国）
- Year and Date
  2015-11-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] New diagnostic and therapeutic target KU-MEL9 for chronic myeloid leukemia(CML)2012
- Author(s)
  Maiko Matsushita, Takuma Suzuki, Naoya Tsutsumida, Shiro Iijima, Nobuo Tsukamoto, Yutaka Kawakami, Eri Matsuski, Shinichiro Okamoto, and Yutaka Hattori
- Organizer
  米国癌研究学会2012年次総会
- Place of Presentation
  シカゴ
- Year and Date
  2012-04-02
- Data Source
  KAKENHI-PROJECT-22791087
[Presentation] 慢性骨髄性白血病における新規治療標的としてのKU-MEL9抗原の検討2012
- Author(s)
  鈴木拓真、松下麻衣子
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌市
- Year and Date
  2012-03-29
- Data Source
  KAKENHI-PROJECT-22791087
[Presentation] 慢性骨髄性白血病(CML)における新規治療標的としてのKU-MEL-9抗原の検討2012
- Author(s)
  鈴木拓真、松下麻衣子、堤田直也、飯島史朗、塚本信夫、河上裕、松木絵里、岡本真一郎、服部豊
- Organizer
  日本薬学会第132年会
- Place of Presentation
  札幌市
- Year and Date
  2012-03-29
- Data Source
  KAKENHI-PROJECT-22791087
[Presentation] New diagnostic and therapeutic target KU-MEL9 for chronic myeloid leukemia2012
- Author(s)
  松下麻衣子
- Organizer
  米国癌研究学会
- Place of Presentation
  米国シカゴ(学会開催3月31日-4月4日)
- Year and Date
  2012-04-02
- Data Source
  KAKENHI-PROJECT-22791087
[Presentation] Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
- Author(s)
  Matsushita M, Nakamura M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
- Organizer
  ISEH 43rd Annual Scientific Meeting
- Place of Presentation
  カナダ　モントリオール
- Year and Date
  2014-08-21 – 2014-08-24
- Data Source
  KAKENHI-PROJECT-26461453

1. 服部豊 (20189575)

# of Collaborated Projects: 3 results

# of Collaborated Products: 13 results
2. 河上裕 (50161287)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
3. 山元智史 (40963369)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 山田健人

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Matsushita Maiko 松下 麻衣子

MATSUSHITA Maiko 松下 麻衣子

Research Projects

Research Products

Co-Researchers

去勢抵抗性前立腺癌に対する細胞外小胞スクリーニング法を用いた新規免疫増強薬の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Why multiple myeloma is incurable?Exploitation of molecular pathogenesis and development of overcoming drug by targeting autophagy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel combined immunotherapy using in silico screening systemPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel immunotherapy targeting leukemic stem cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of immunotherapy targeting melanoma stem cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of induction mechanisms for tumor antigen-specific regulatory T cells in lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication2009

Author(s)

Journal Title

Data Source

[Journal Article] Chimeric antigen receptors combining, 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.2009

Author(s)

Journal Title

Data Source

[Presentation] 多発性骨髄腫に対して免疫原性細胞死を誘導する天然物由来化合物の安全性と有効性の検討2023

Author(s)

Organizer

Data Source

[Presentation] エピジェネテイック因子CDYL2は多発性骨髄腫におけるレナリドミド感受性を減弱する2023

Author(s)

Organizer

Data Source

[Presentation] Characteristics of Cytotoxic T Cells against Myeloma Cells for Adoptive Immunotherapy.2019

Author(s)

Organizer

Data Source

[Presentation] A novel candidate for immunological target in treatment of multiple myeloma.2019

Author(s)

Organizer

Data Source

[Presentation] プロテアソーム阻害薬の免疫原性細胞死による免疫調節機能2018

Author(s)

Organizer

Data Source

[Presentation] Analysis of immunogenic cell death (ICD) induced in multiple myeloma cells.2018

Matsushita Maiko 松下麻衣子

MATSUSHITA Maiko 松下麻衣子